Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.052 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.07 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |